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Background: Ventilator-associated pneumonia (VAP) is a common clinical problem. 
Previous studies involving adult patient cohorts have assessed various risk factors 
associated with VAP, including ventilator circuit changes. The objective of this study 
was to examine the incidence of and risk factors associated with VAP, particularly 
3-day versus 7-day ventilator circuit changes, in a pediatric intensive care unit (PICU).
Methods: This was a cohort observational study. Patients hospitalized in the PICU at 
Chang Gung Children’s Hospital between November 2003 and September 2004 were 
enrolled. Investigators and critical-care specialists evaluated baseline characteris-
tics, incidence of VAP, and related variables from PICU admission until discharge or 
death.
Results: Of 397 patients initially enrolled, 96 (aged 11−60 months) were available 
for statistical analysis and were assigned into two groups according to timing of 
ventilator circuit change: 3-day (n = 46) and 7-day circuit change (n = 50). No statisti-
cally significant differences were observed for VAP incidence (13% vs. 16%, p = 0.68) 
or hospital mortality (22% vs. 36%, p = 0.14) for 3-day versus 7-day circuit change. 
Incidence of VAP per 1000 ventilation days was 10.75 and 8.41 for 3-day and 7-day 
circuit change, respectively. Univariate analysis indicated statistical significance 
for the duration of mechanical ventilation (10.17 ± 16.63 days vs. 18.20 ± 14.99 days, 
p < 0.001), length of stay in PICU (22.30 ± 20.48 days vs. 37.22 ± 36.79 days, p = 0.0069) 
and presence of enteral nutrition [7 (15.22%) vs. 23 (46.0%), p = 0.0012].
Conclusion: Weekly circuit change does not contribute to increased rates of VAP 
in pediatric patients. Long-term studies evaluating risk factors in larger pediatric 
patient populations are warranted for further conclusive recommendations.
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1.  Introduction
Ventilator-associated pneumonia (VAP) is a noso-
comial infection occurring ≥ 48 hours after institut-
ing mechanical ventilation. Pharyngeal colonization 
results in circuit colonization.1,2 The known causa-
tive factors of VAP include contaminated ventila-
tor tubing condensate, reduced gastric activity as 
a result of antibiotic therapy, stress ulcer prophy-
laxis, supine head positioning, parenteral nutrition, 
nasogastric intubation and poor hand washing.3−6 
The 2006 US National Healthcare Safety Network 
(NHSN) data summary reported a pooled mean inci-
dence of VAP at pediatric intensive care units (PICU) 
of 2.5 per 1000 ventilator days.7 The incidence of 
VAP varies worldwide, ranging from 1.7 to 8.9 per 
1000 ventilator days. While blood stream infections 
are the most common nosocomial problem in the 
PICU, VAP is the infection with the highest mortal-
ity rate, at 8%, for deaths directly attributable 
to VAP.8,9
Studies evaluating correlations between respi-
ratory equipment and the development of VAP have 
proposed the biofilm in endotracheal tubes and 
ventilator circuit changes as possible contributing 
factors. While one study in neonates failed to dem-
onstrate a correlation between the presence of the 
film and nosocomial infection, another study showed 
that 70% of pathogens recovered from the endotra-
cheal tube were genotypically the same as those 
recovered from tracheal secretions in patients with 
VAP.10−12 Thus, whether endotracheal tubes and 
biofilm are risk factors for VAP or not has yet to be 
determined.
The other factor associated with VAP is the 
frequency at which ventilator circuit is changed. 
Currently, maintaining circuit integrity with less 
frequent circuit changes, with or without a heat-
and-moisture filter, is preferred and prevents the 
introduction of nosocomial pathogens. Cost savings 
are an additional benefit resulting from the re-
duced use of disposable equipment and circuit 
maintenance.13−15 Guidelines from the American 
Association of Respiratory Care on the care of ven-
tilator circuits recommend that the “Ventilator 
circuit should not be changed routinely for infec-
tion control purposes [as] available evidence sug-
gests that no patient harm and considerable cost 
savings are associated with extended ventilator-
circuit change intervals. The maximum duration 
of time that circuits can be used is not known.”16 
However, most of the current practices and con-
clusions are based on studies in adult patients with 
necessity-based ventilator use and interventions 
designed to accelerate weaning from mechanical 
ventilation, including early extubation, use of non-
invasive ventilators and weaning protocols.17,18
The incidence of VAP in pediatric populations 
and the relationship between VAP and frequency 
of ventilator circuit change have been less exten-
sively studied. Large neonatal intensive care units 
(ICUs) in the United States prescribe ventilator cir-
cuit changes every 2−7 days.19 Prior to this study, a 
3-day ventilator circuit change was routine in our 
PICU. The objective of this study was to measure 
the incidence of VAP within a PICU in a teaching 
hospital and to observe if there was a difference 
in incidence of VAP and mortality in patients on a 
3-day versus 7-day ventilator circuit change regimen.
2. Materials and Methods
2.1. Study location and patients
We conducted this observational study between 
November 2003 and September 2004 at the Chang 
Gung Children’s Hospital, which has a 29-bed PICU 
staffed by two pediatric critical care intensivists, 
two pediatric critical care fellows, one pediatric 
cardiologist, one pediatric cardiology fellow, and two 
3rd-year residents. Patients were cared for by the 
attending physicians and residents rotating on a 
weekly or monthly basis, with a maximum nurse-
to-patient staffing ratio of 1 to 3. Eligible patients 
were those that required ventilator support with 
primary endotracheal intubation performed within 
the PICU. The exclusion criteria were, (1) patients 
extubated or who died within 72 hours of admis-
sion; (2) pre-existing artificial airway/tracheostomy 
and/or ventilator use at admission; (3) non-invasive 
ventilator use (bi-level positive airway pressure or 
continuous airway pressure); (4) premature circuit 
change; (5) pneumonia diagnosed prior to intuba-
tion. Premature circuit change was defined as a 
circuit change made before the scheduled date, 
according to the protocol, due to severe circuit 
air leak, endotracheal tube obstruction, or grossly 
solid condensate deposited in the circuit. All study 
protocols were performed in accordance with pre-
vious guidelines prescribed by the director of pedi-
atric critical care and emergency medicine and the 
Institutional Review Board at Chang Gung Children’s 
Hospital.
2.2. Study design and data collection
This was an observational cohort study. We divided 
the admitted children on a chronologic basis. Patients 
who were admitted between November 1, 2003, and 
April 30, 2004, received ventilator circuit changes 
every 3 days. Patients who were admitted between 
May 1, 2004 and September 30, 2004, received ven-
tilator circuit changes every 7 days. The ventilators 
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used were Siemens Servo 300 (Siemens-Elema, Solna, 
Sweden), Puritan-Bennett 7200 (Nellcor Puritan 
Bennett, Pleasanton, CA, USA), VIB Bird and HFOV-
SensorMedics 3100A, B (Viasys Healthcare, Yorba 
Linda, CA, USA). The ventilator circuits (Hytrel Tube; 
Fisher and Paykel Co., Irvine, CA, USA) included gas 
delivery tubing, humidifier water reservoirs, water 
traps and medication delivery devices. All venti-
lator circuits were disposable, equipped with a 
Y-connector, and contained an attached trap to col-
lect tubing condensate. Ventilator circuits were 
changed at any time at the discretion of the indi-
vidual physicians or the respiratory therapists. 
Patients transferred for surgical intervention, 
while in the PICU, received the same ventilator 
and circuit upon return to the PICU to minimize 
unscheduled circuit changes. Ventilator circuits 
were monitored at least once every 2 hours and 
water traps were emptied when filled.
Upon admission, demographic and baseline char-
acteristics were collected; these included age, 
sex, presence of concomitant systemic underlying 
disease(s), and Pediatric Risk of Mortality (PRISM) 
score. Concomitant systemic underlying disease was 
defined as the presence of congenital heart dis-
eases, bronchopulmonary dysplasia, severe central 
nervous system diseases or myopathy, severe he-
reditary metabolic or chromosomal diseases, malig-
nancy, or post-transplant status. Medical or surgical 
interventions during admission thought to predis-
pose patients to VAP, including transfusions, type 2 
histamine receptor antagonist or proton pump in-
hibitors, tracheostomy, fiberscopy (pandoscopy or 
bronchoscopy) and extracorporeal circuit use (such as 
extracorporeal membrane oxygenation and contin-
uous renal replacement therapy) were also recorded.
The primary outcome was incidence of VAP. 
Secondary outcomes were hospital mortality, length 
of PICU stay, total number of ventilation days for 
a single intubation, successful extubations, and 
deaths directly attributable to VAP. The study pa-
tients were monitored for occurrence of VAP on a 
daily basis until successful extubation in the PICU 
or death.
2.3.  Definitions
PRISM is a validated, generic, mortality scoring sys-
tem counted during a 24-hour observation period 
for children admitted to PICUs.20
The diagnostic protocols for VAP were applied in 
accordance with criteria prescribed by the NHSN.21 
PICU flow sheets were reviewed daily, in conjunction 
with microbiological culture and radiology results, 
to determine pneumonia.
A diagnosis of pneumonia was established ac-
cording to the NHSN algorithm for clinically defined 
pneumonia when one of the following was observed 
on radiographic analysis: new or progressive and per-
sistent infiltrate lasting > 48 hours; consolidation; 
or cavitation with any of the following: (1) fever 
(> 38°C or > 100.4°F) with no other recognized cause; 
(2) leukocytes ≥ 12.0 × 106/L or leukopenia with leu-
kocytes < 4.0 × 106/L; (3) worsening gas exchange with 
O2 desaturation (PaO2/FiO2 ≤ 240), increased oxygen 
requirements, or increased ventilator demand; (4) 
new onset of purulent sputum, defined as the pres-
ence of 25 leukocytes and < 10 squamous cells per 
high power (100×) field; or (5) new onset of cough, 
dyspnea or tachypnea.
Microorganisms were determined by endotracheal 
aspirate culture. VAP cases were further divided into 
early-onset VAP (occurring < 5 days of mechanical 
ventilation) and late-onset VAP (occurring ≥ 5 days 
of mechanical ventilation).22
2.4. Statistical analysis
Demographic data are presented as means and 
standard deviation, median and interquartile range, 
and frequency/percentage in parentheses. Univariate 
comparisons were made using Wilcoxon rank sum 
and χ2 tests, depending on statistical distributions. 
Log-rank tests for equality of survival curves across 
strata and multivariate logistic regression were used 
to evaluate incidence of VAP. All data were ana-
lyzed using SAS version 9.0 (SAS Institute Inc., Cary, 
NC, USA), and significance level was 0.05. Power 
analysis, computed a priori with STPLAN version 4.2 
(University of Texas, MD Anderson Cancer Center, 
Houston, TX, USA) was based on differences in the 
incidences of VAP. Preliminary estimates of the in-
cidence showed that a sample size of 45 per group 
would yield a power of 80% to detect a difference 
of at least 0.05 in the incidence of VAP between 
the two comparison groups, assuming a 5% level of 
significance.
3.  Results
A total of 397 patients were enrolled in the study 
(Figure 1). Of these, 192 patients were enrolled in 
the 3-day circuit change group while 205 patients 
were enrolled in the 7-day circuit change group ac-
cording to the time of admission. Fifty-five patients 
(3-day group, n = 22; 7-day group, n = 33) were ex-
cluded due to non-invasive ventilator use. Another 
176 patients (3-day group, n = 94; 7-day group, n = 
82) were subsequently excluded due to pre-existing 
artificial airway use in a previous PICU admission. 
Further screening resulted in 76 patients in the 3-day 
circuit change group and 90 in the 7-day group. 
Sixteen patients in the 3-day group and 27 patients 
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in the 7-day group died or were extubated within 
3 days. Fourteen patients in the 3-day group and 
13 in the 7-day group were excluded due to pre-
mature circuit change. Finally, the 3-day circuit 
change group comprised 46 patients and the 7-day 
circuit change group 50 patients.
The baseline characteristics are shown in Table 1. 
Of the 96 patients in both groups, 52.2% (24/46) 
of the 3-day group and 54.0% (27/50) of the 7-day 
group were males. Both study groups were similar 
in age (3-day vs. 7-day, 39.93 ± 43.76 months vs. 
62.54 ± 61.14 months, p = 0.818). The incidence of 
concomitant underlying systemic disease was low 
in both groups. Specific medical and/or surgical 
interventions during PICU admission were similar 
in both groups except for parenteral nutrition use 
[7 (15.2%) vs. 23 (46.0%), p = 0.001].
The two variables that were significantly differ-
ent between the two groups are the total duration 
of mechanical ventilation (10.17 ± 16.63 days vs. 
18.20 ± 14.99 days, p < 0.001) and the length of stay 
in PICU (22.30 ± 20.48 days vs. 37.22 ± 36.79 days, 
p = 0.007).
As shown in Table 2, VAP occurred in six (13.0%) 
patients in the 3-day group and eight (16.0%) pa-
tients in the 7-day group. In the 3-day group, three 
patients had positive sputum cultures (oxacillin-
resistant Staphylococcus aureus, enterobacter and 
pseudomonas), while in the 7-day group, five had 
positive sputum cultures [Escherichia coli (1), 
3-day group (192) 
(November 1, 2003 to April 30, 2004) 
Excluded patients (146) 
 Non-invasive ventilator use (22) 
 Pre-existing artificial airway before admission (94) 
 Died or extubated within 3 days (16) 
 Premature respiratory circuit exchange (14) 
7-day group (205) 
(May 1, 2004 to September 30, 2004) 
Excluded patients (155) 
Non-invasive ventilator use (33) 
Pre-existing artificial airway before admission (82) 
Died or extubated within 3 days (27) 
Premature respiratory circuit exchange (13) 
Analyzed (46) Analyzed (50) 
PICU patients who received mechanical ventilation during the study period (N = 397)∗
Figure 1 Study flowchart. *Number of cases is expressed as (n). PICU = pediatric intensive care unit.
Table 1 Baseline characteristics of patients allocated to the 3-day and 7-day circuit change
Characteristics 3-day change (n = 46)* 7-day change (n = 50)* p†
Age (mo)‡ 39.93 ± 43.76 52.54 ± 61.14
 21.50 (11.0−52.0) 27.00 (7.0−60.0) 0.82
Male 24 (54.4%) 27 (54.0%) 0.97
Presence of concomitant underlying 29 (63.0%) 33 (66.0%) 0.76
 systemic disease on admission
PRISM score‡ 13.0 ± 5.8 13.5 ± 7.1
 12 (9−16) 18 (13−21.5) 0.50
Mechanical ventilation duration (d)‡  10.17 ± 16.63 18.20 ± 14.99
 5 (4−10) 14.5 (8−22) < 0.001§
Length of PICU stay (d)‡ 22.3 ± 20.5 37.2 ± 36.8
 17 (8−28) 27 (15−51) 0.007§
Successful extubation 36 (78.3%) 32 (64.0%) 0.13
H2-blocker use and/or proton pump inhibitor 19 (41.3%) 18 (36.0%) 0.59
Parenteral nutrition 7 (15.2%) 23 (46.0%) 0.001§
Fiberscopy 9 (19.6%) 18 (36.0%) 0.07
Tracheostomy 2 (4.3%) 5 (10.0%) 0.44
Transfusion 21 (45.7%) 28 (56.0%) 0.31
Extracorporeal circuit use|| 4 (8.7%) 6 (12.0%) 0.60
*Data are presented as n (%), mean ± standard deviation or median (interquartile range); †χ2 test; ‡Wilcoxon rank sum test; 
§p < 0.05; ||extracorporeal circuit use includes hemodialysis, continuous renal replacement therapy, continuous arterio-venous 
hemofiltration or extracorporeal membrane oxygenation. PRISM = Pediatric Risk of Mortality; PICU = pediatric intensive care unit.
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Klebsiella oxytoca (1), oxacillin-resistant Staphy-
lococcus aureus (1), and pseudomonas (3)]. Early-
onset VAP occurred in 66.7% (4/6) and 50.0% (4/8) 
of patients who developed VAP in the 3-day and 
7-day groups, respectively. There were 10 (21.7%) 
and 18 (36.0%) mortalities in the 3-day and 7-day 
groups. Deaths related to VAP occurred in 10.0% 
(1/10) and 33.3% (6/18) of patients in the 3-day and 
7-day groups, respectively. The total duration of 
ventilation was 113 days for the 3-day group and 70 
days for the 7-day group. Incidence of VAP per 1000 
ventilation days was 10.75 and 8.41, respectively. 
No statistical significance was observed for these 
variables (p > 0.05). A multivariate logistic model 
was developed to evaluate the VAP rate after ad-
justing for the total duration of mechanical ventila-
tion and length of stay in PICU (not shown). However, 
no significant difference between the two groups 
were found (p = 0.63).
4.  Discussion
This was an observational cohort study focusing on 
the relationship between the frequency of ventila-
tor circuit change and VAP in the PICU setting. We 
found that extending the use of ventilator circuit 
from 3 days to 7 days did not significantly affect 
VAP incidence or contribute to deaths related to VAP 
(p > 0.05) in our PICU. The difference between VAP 
occurrence and deaths between the two groups 
might be attributable to more patients enrolled in 
the 7-day circuit group who later developed multi-
ple organ failure during their PICU stay. However, 
the results of this study cannot statistically con-
firm the conventional opinion that extending the 
circuit change intervals from 3 days to 7 days reduces 
the rate or risk of VAP.13,14,23,24
Four limitations may have compromised the 
statistical integrity of the study. Firstly, the PRISM 
score did not reflect the “exact” illness severity 
during the entire PICU course. Secondly, the sched-
uled difference between the 3-day and 7-day ven-
tilator circuit change groups may inherently affect 
the length of time for mechanical ventilation (i.e., 
the 7-day group had longer baseline mechanical 
ventilation days). Thirdly, we did not use protocol-
driven weaning profiles, such as daily testing of 
patient readiness for extubation, and the individ-
ual physician decision bias may have influenced 
mechanical ventilation duration and even length 
of stay in PICU. Lastly, we did not strictly adhere 
to the VAP preventative procedure, which may have 
reduced overall VAP incidence substantially.
Seasonal variations may also affect the pattern of 
PICU admission because in winter time, respiratory 
diseases tend to contribute to more admissions while 
in summer time, enteroviral infections tend to con-
tribute to more admissions. However, in our study, 
we did not see perennial variations in the basic 
characteristics of our enrolled patients. There were 
two reasons that might explain this. Firstly, we ex-
cluded cases with diagnosed pneumonia prior to PICU 
admission during the initial enrollment. This step 
likely reduced the seasonal admission variation. 
Secondly, we excluded cases with a pre-existing 
artificial airway, previous ventilator use, or non-
invasive ventilator use during enrollment. Together, 
these represent a diverse range of inherent endemic 
risks that we wanted to avoid during this study.
Until the 1990s, contamination of respiratory 
support equipment was considered a significant 
source of nosocomial respiratory tract infection.25 
It is now clear that routine, frequent changes of 
the ventilator circuit are not necessary in neonatal 
or adult ICUs.1,15,19 Results of the current study are 
in agreement with other studies to date.1,13,15,19,26 
Dreyfus et al1 in a randomized study, found no dif-
ference in the incidence of VAP between 2-day and 
7-day circuit changes with heated humidification. 
Similarly, Hess et al26 when compared 2-day with 
7-day circuit changes in 3423 adult patients, found 
Table 2 Correlation between ventilator-associated pneumonia and circuit change frequency
Variable 3-day change (n = 46)* 7-day change (n = 50)* p
Number of patients with VAP† 6 (13.0%) 8 (16.0%) 0.68
Duration of VAP (d)‡ 14.5 (4−17) 10 (4−16) 0.62
Hospital mortality§ 10 (21.7%) 18 (36.0%) 0.14
Deaths directly related to VAP 1 (10.0%) 6 (33.3%) 0.13
Ventilation days (total)‡ 113 200 0.05
VAP/1000 ventilation days 10.75 8.41 0.33
*Data are presented as n (%) or median (interquartile range); †compared with χ2 tests; ‡compared with Wilcoxon rank sum test; 
§compared with log-rank test for time to death in hospital and the denominator is the number of subjects assigned to each group; 
compared with log-rank test for time to VAP death and the denominator is hospital mortality. VAP = ventilator-associated 
pneumonia.
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no difference in the incidence of VAP (5.6% vs. 4.6%). 
Kollef et al15 studied having no routine circuit changes 
versus 7-day circuit changes, but noted no differ-
ence in VAP occurrence between the two groups, 
with a non-significant relative risk of 0.85 (95% confi-
dence interval: 0.55−1.17). In one of the few stud-
ies examining neonatal population, Makhoul et al19 
examined the incidence of VAP in premature infants 
following circuit changes of 1 day versus 3 days. 
They reported that increasing the frequency of cir-
cuit change from 1 day to 3 days did not increase 
the occurrence rate of VAP, and reported no statis-
tically significant difference in duration of hospi-
talization and hospital mortality between the two 
groups.19 Meta-analysis of the same data however, 
revealed a reduced odds ratio (0.82, p = 0.22) for 
developing VAP in the 7-day circuit change group.13
In contrast, some studies have also found sig-
nificant differences when the frequency of circuit 
change was varied.14,23,27,28 Fink et al14 assessed cir-
cuit changes at 2 days, 7 days and 30 days in a study 
conducted between January 1991 and December 
1994. They found that the incidence of VAP per 1000 
ventilator days was 11.88, 3.42 and 6.28 for 2-day, 
7-day and 30-day circuit changes, respectively.14 
Han et al23 and Lien et al27 compared 2-day with 
7-day circuits in two separate studies and found 
a reduction in VAP rate from 9.2% to 3.5% in the 
7-day group but Lien et al found no difference in the 
VAP rate (2.9% vs. 3.2%) between the two groups. 
Stamm28 reviewed six studies that compared the 
VAP rates with 2-day versus 7-day circuit changes 
and found that the evidence supported less frequent 
circuit changes.
With regard to the issue of why more frequent 
circuit changes could lead to higher incidence of 
VAP, Craven et al5 and the American Association of 
Respiratory Care guidelines16 proposed that “break-
ing the circuit” may result in flushing contaminated 
tubing condensate into the patient or increasing 
the lavage of bacteria into the trachea from around 
the endotracheal tube due to unnecessary manipu-
lation of the patient, endotracheal tube or venti-
lator tubing. The Centers for Disease Control and 
Prevention recommends routine ventilator circuit 
changes for grossly visible contamination of the 
circuit with blood, emesis or purulent secretions.29 
These measures may not only reduce the overall 
VAP occurrence rates and exposure of patients and 
healthcare providers to infectious aerosols, but also 
lower the cost and labor associated with frequent 
circuit changes.
In terms of cost-effectiveness, Hess26 reported 
that 7-day circuit changes reduced annual costs 
incurred for maintenance and salaries by 76.6% 
(US$113,530). In Taiwan, we could not calculate the 
total cost associated with respiratory circuit exchange 
because of the bundled payment system for me-
chanical ventilation. However, the positive effect on 
resource conservation should be substantial in the 
absence of costs attributed to an increase in VAP.
When compared with adults, intubated children 
supported on mechanical ventilation have similar 
and unique risk factors for developing VAP. Similar 
risks include aspiration or oropharyngeal or gastric 
secretions. Unique risks include incomplete den-
tition and use of uncuffed endotracheal tubes.30 
Additional risk factors in adults include the dura-
tion of mechanical ventilation and prolonged ICU 
stay.3,6,31 We found that duration of mechanical 
ventilation and length of stay in PICU were signifi-
cant risk factors for the development of VAP, simi-
lar to findings reported by Edwards et al.32 They 
noted that the 34 patients who had VAP (out of 595 
mechanically ventilated patients) had longer length 
of stay in PICU (27.53 ± 20.09 days, p = 0.001). They 
also addressed two risk factors not specifically 
assessed in our study, namely higher mean PRISM 
score and longer duration of hospital stay.32
In this study, the incidence of VAP per 1000 ven-
tilator days was 10.75 and 8.41 for 3-day and 7-day 
circuit changes, similar to the upper average re-
ported in the literature.9 Edwards et al32 reported 
a pooled mean VAP of 11.6 cases per 1000 ventilator 
days. The results of the current study may be related 
to several factors in our PICU: a high prevalence of 
prolonged multiple antibiotic use, reduced adher-
ence to hand-washing, absent routine in-line suction, 
and less strict use of the semi-recumbent position 
rather than the supine position. Brilli et al33 re-
ported that implementing specific VAP-preventative 
measures with a checklist of actions and tasks in a 
PICU setting significantly reduced the VAP rates from 
6.6 cases per 1000 ventilator days to 0.5 cases per 
1000 ventilator days (p < 0.05), suggesting that im-
plementing and adhering to such measures could 
significantly reduce the incidence of VAP.
Given the paucity of specific pediatric research, 
many low-risk practices validated in the adult pop-
ulation are implemented in the pediatric critical 
care setting without appropriate testing. We per-
formed this observational study so as to obtain 
direct evidence for less-frequent circuit changes. 
Results of the current study confirm that prolong-
ing the time between VAP circuit changes from 3 days 
to 7 days in the PICU does not contribute to the 
incidence of or mortality due to VAP, similar to re-
sults from adult ICU studies. In recent years, strict 
VAP preventative procedures have been implemented 
in adult ICUs and in some PICU settings, resulting 
in a significant reduction in the incidence of VAP and 
reduced treatment costs.30,33 Further research is 
warranted to prospectively evaluate VAP preventa-
tive procedures in PICU settings.
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